15/06/2011 New terms and conditions applicable on July 1rst, 2011

Nouvelles conditions générales de vente applicables au 1er juillet 2011. Consulter.Nieuwe algemene verkoopsvoorwaarden geldig vanaf 1 juli 2011. Klik hier.


22/03/2011 Updated information about NSF and Dotarem

Information for Healthcare Professionals and other Stakeholders


05/01/2011 Price lowering Xenetix

Due to INAMI/RIZIV decision (reimbursement 12 y.) prices of the whole range of Xenetix have fallen by 15 % from January 01, 2011 in Belgium. See price list.


19/11/2010 Change of the Codali name from December 1st, 2010

Due to name harmonization of the Guerbet affiliates, sa Codali nv becomes sa Guerbet nv from December 1st, 2010. Click on file for more information. letter FR letter NL


19/11/2010 T. Ishiguchi & Dotarem (Drugs RD 2010)

A study conducted on 3.444 patients during 4 year showed an excellent (99,53 %) global efficacy rate as well as a very good safety of Dotarem :


Displaying results ###SPAN_BEGIN###%s to %s out of ###SPAN_BEGIN###%s